CAT DEVANT UN ICTERE PDF

Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia. TNE de sites rares ou inhabituels 2. Expert Rev Anticancer Ther. Int J Biol Markers.

Author:Karr Kazuru
Country:Venezuela
Language:English (Spanish)
Genre:Business
Published (Last):17 October 2004
Pages:363
PDF File Size:1.98 Mb
ePub File Size:3.9 Mb
ISBN:246-8-97679-185-1
Downloads:53437
Price:Free* [*Free Regsitration Required]
Uploader:Tojagar



Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. Detection of liver metastases from endocrine tumors: Weatherstone K, Meyer T. Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract. International histological classification of tumours. Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?

International Angency for Research on Cancer Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. Gemcitabine and oxaliplatin or devantt agents for neuroendocrine tumors: Intervention in gastro-enteropancreatic neuroendocrine tumours. A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas.

N Engl J Med. Cadiot G, Mignon M. Streptozocin-based chemotherapy is not history in neuroendocrine tumours. J Interferon Cytokine Res ; Effect of short-term proton pump inhibitor hn and its discontinuation on chromogranin A in healthy subjects.

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors. WHO classification of tumours of the digestive system. TNE gastrique sporadique i. Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia. Review and Position Statement. New treatment strategies in advanced neuroendocrine tumours.

Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. Prognostic factors influencing survival from metastatic stage IV gastroenteropancreatic well-differentiated endocrine carcinoma. Suspicion de tumeur mixte comportant un contingent neuroendocrine. Antonodimitrakis P et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in citere control oftumor growth in patients with metastatic neuroendocrine midgut tumors: Devannt classification OMS des TNE digestives ne prenait pas en compte ces tumeurs, mais la nouvelle classification les inclut annexe 1.

Am J Gastroenterol ; Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors. TOP Related Articles.

ZERO WILLPOWER EATING SYSTEM PDF

Conduite à tenir devant un ictère

.

INTERNATIONAL MARKETING DANA NICOLETA LASCU PDF

Cat devant un icter cholestatique

.

Related Articles